Valley National Advisers’s CervoMed CRVO Stock Holding History

Valley National Advisers’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13	Closed	-$1K	–	781
2020 Q2	$1K	Buy	+13	New	+$791	﹤0.01%	702

Other funds holding CRVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Valley National Advisers's CRVO Position: Q3 2020 in Review

Valley National Advisers sold out of CervoMed (CRVO) in Q3 2020, closing a stake of 13 shares — an estimated $1K sold.

Valley National Advisers first reported a position in CRVO in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 22 funds tracked by Wall St. Rank hold CRVO as of Q3 2020.

Valley National Advisers reported no remaining CervoMed position as of Q3 2020 after selling out during the quarter.
Valley National Advisers sold 13 CervoMed shares in Q3 2020, an estimated $1K.
Valley National Advisers first reported a position in CervoMed in Q2 2020 and held it in 1 quarter.
Valley National Advisers's CervoMed position peaked at $1K in Q2 2020.
22 funds tracked by Wall St. Rank held CervoMed as of Q3 2020.

Based on Valley National Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.